We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Silencing Masks the Malaria Parasite

By Biotechdaily staff writers
Posted on 28 Apr 2005
Researchers have identified a mechanism used by the malaria parasite Plasmodium falciparum to regulate the var gene responsible for the manufacture of the variable surface protein PfEMP1, which hides the parasite from the host's immune response. More...
While the P falciparum genome contains at least 50 var genes, only one is expressed at any given time, giving rise to a single version of the PfEMP1 protein.

Investigators at The Walter and Eliza Hall Institute of Medical Research (Melbourne, Australia) studied the region around the var gene by inserting a gene for drug resistance adjacent to it. They reported in the April 8, 2005, issue of Cell that a process of gene silencing was operating. In some parasites, the DNA region was active, and the parasites showed resistance to the drug. In others, the drug killed the parasites.

Gene silencing suggested the involvement SIR2 (silent information regulator 2) protein, which was known to play a role in gene silencing in yeast by modifying gene packaging. To learn what SIR2 was doing, the investigators developed a parasite line that lacked the SIR2 gene. "Silencing occurs by packaging up the DNA into a tight form and preventing it from being expressed. That tight packaging involves SIR2,” said senior author Dr. Alan Cowman, professor of infection and immunity at The Walter and Eliza Hall Institute of Medical Research.

Another potential control mechanism for gene silencing is compartmentalization. The investigators used fluorescence in situ hybridization (FISH), a technique that employs fluorescent-labeled probes specific for particular segments of DNA, to determine the position of var genes in "on” and "off” states. They found that there appeared to be discrete nuclear compartments that allowed gene expression to occur. When a var gene moved into this compartment, it became activated and its version of PfEMP1 was expressed.

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.